A phase I study of binimetinib, a MEK inhibitor, in combination with pembrolizumab in patients with advanced non-small cell lung cancer (NSCLC)
Christopher F. Theriau, Jamie Feng,Lawson Eng,Frances A. Shepherd, Mary DeCarolis, Vivian Glenns,Swati Kulkarni, Rachel VanderMeer, Urszula Zurawska-Fortin,Desiree Hao,Lisa Le, Isabel Wozniczka, Aida Al-Kindy, Danny Xie,Tong Zhang, Vasanth Subramanian,Tracy Stockley,Penelope A. Bradbury,Geoffrey Liu,Natasha B. Leighl CANCER RESEARCH（2023）
AI 理解论文
溯源树
样例
